RE: So suddenly a CLINICAL Pharma about to enter trials is worth..20 Mar 2024 14:00
I emailed all the HEMO BOD and others a couple of weeks ago on roughly the same theme. March 8th to be exact. I was simply showing concern for the SP and asking why do they believe HEMO and it's products simply do not get the recognition from their Peers and the Investment community in general and what is the plan to raise the bar. I also added I have friends who manage Funds and I have sung the praises of the company for years, and after they have then looked at the Web Site the responses I received from them were not complementary should I say. This was also included in my correspondence to them.
This is the response I received;
" We note your concerns and please be assured that we are actively considering these matters and what action we can take. However, it is difficult for us to enter into dialogue with individual shareholders as I hope you will understand.
Best regards,
Hemogenyx Pharmaceuticals LLC
1361 Amsterdam Ave., Ste. 320, New York, NY 10027
Phone: (347) 735-8380
I replied back after thanking them for replying saying I do not or did want any specific information, just a warm feeling they are trying to do something about it, because the SP should simply not be this low and really concerns LTH's like myself and others as it appears the HEMO BOD are happy to have the SP worth the value of less that a Beano comic when we supposedly have Medical miracles in the pipeline.